Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy. in Italian journal of pediatrics / Ital J Pediatr. 2024 Mar 25;50(1):57. doi: 10.1186/s13052-024-01628-7.
2024
ASL Cuneo 1
ASL Cuneo 2
Tipo pubblicazione
Observational Study
Autori/Collaboratori (16)Vedi tutti...
Baraldi E
Neonatal Intensive Care Unit, Department of Woman's and Child's Health, Padova University Hospital, Padova, Italy.
Perrone V
CliCon Società Benefit S.r.l., Health, Economics & Outcomes Research, Via Murri 9, Bologna, 40137, Italy.
Parisi S
Sanofi Vaccines, Milan, Italy.
et alii...
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in children younger than 5 years worldwide and the second cause of infant death after malaria. RSV infection occurs in almost all the infants before the second year of life with variable clinical severity, often requiring medical assistance. This analysis investigated patients aged 0-5 years with RSV infection focusing on epidemiology, clinical features, and economic burden of RSV-associated hospitalizations in a setting of Italian real clinical practice. METHODS: An observational retrospective analysis was conducted on administrative databases of healthcare entities covering around 2.6 million residents of whom 120,000 health-assisted infants aged?
Accesso banca dati bibliografica
Accedi alla scheda bibliografica del documento in PUBMED
PMID : 38528616
DOI : 10.1186/s13052-024-01628-7
Keywords
Infants; Children; Respiratory Syncytial Virus, Human; Premature Birth; Hospitalization; Financial Stress; Retrospective Studies; Respiratory Syncytial Virus Infections/epidemiology/therapy/diagnosis; Child; Infant, Newborn; Humans; Female; Infant; Monoclonal antibodies; Prevention of RSV; Real-world evidence; Respiratory syncytial virus;